IBERE PHARMACEUTICALS

Ibere Pharmaceuticals is a pharmaceutical company.

#More

IBERE PHARMACEUTICALS

Founded:
2020-01-01

Address:
Philadelphia, Pennsylvania, United States

Country:
United States

Total Employee:
1+

Status:
Active

Contact:
267-765-3222


Stock Details


Company's stock symbol is NYSE:IBERU

More informations about "Ibere Pharmaceuticals"

Ibere Pharmaceuticals โ€“ New Beginnings

Ibere Pharmaceuticals โ€“ New BeginningsSee details»

Ibere Pharmaceuticals - Crunchbase Company Profile & Funding

Ibere Pharmaceuticals is a pharmaceutical company. Ibere Pharmaceuticals, which manages internationally known brands and develops clinical assets through food and drug โ€ฆSee details»

Ibere Pharmaceuticals (IBER) 10K Annual Reports & 10Q SEC Filings

Mar 31, 2022 Ibere Pharmaceuticals : Entity Incorporation, State or Country Code: E9 : Entity Tax Identification Number: 86-2933776 : Entity Address, Address Line One: 2005 Market โ€ฆSee details»

SEC.gov | HOME

Sep 30, 2021 description of organization and business operations Ibere Pharmaceuticals (the โ€œCompanyโ€) is a blank check company incorporated as a Cayman Islands exempted company โ€ฆSee details»

Ibere Pharmaceuticals Company Profile | Management and

Ibere Pharmaceuticals Profile and History Ibere Pharmaceuticals is a newly formed special purpose acquisition company that completed its initial public offering in March 2021 ,Led by โ€ฆSee details»

Ibere Pharmaceuticals - Funding, Financials, Valuation & Investors

Feb 26, 2021 Ibere Pharmaceuticals is registered under the ticker NYSE:IBERU . Their stock opened with $10.00 in its Feb 26, 2021 IPO. Stock Symbol NYSE:IBERU ; Money Raised at โ€ฆSee details»

Ibere Pharmaceuticals - Overview, News & Similar companies

Ibere Pharmaceuticals is a newly formed special purpose acquisition company that completed its initial public offering in March 2021 ,Led by Osagie O. Imasogie , Lisa Gray and Zoltan โ€ฆSee details»

Ibere Pharmaceuticals - Company Profile and News

Ibere Pharmaceuticals operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, โ€ฆSee details»

Ibere Pharmaceuticals Announces Redemption of Public Shares โ€ฆ

Ibere Pharmaceuticals Announces Redemption of Public Shares and ...See details»

Private equity manager's SPAC Ibere Pharmaceuticals files for

Feb 9, 2021 Ibere Pharmaceuticals was founded in 2020 and plans to list on the NYSE under the symbol IBERU. The company filed confidentially on December 7, 2020. Raymond James โ€ฆSee details»

Ibere Pharmaceuticals to Redeem Shares and Dissolve Next Month

Feb 16, 2023 Ibere Pharmaceuticals announced that it will redeem shares effective at the close of business March 2 as the SPAC will not complete an initial business combination by its โ€ฆSee details»

Ibere Pharmaceuticals Announces the Separate Trading of its Class โ€ฆ

Apr 19, 2021 About Ibere Pharmaceuticals. Ibere Pharmaceuticals is a newly formed special purpose acquisition company that completed its initial public offering in March 2021, raising โ€ฆSee details»

Ibere Pharmaceuticals Announces Redemption of Public Shares โ€ฆ

PHILADELPHIA, Feb. 15, 2023 /PRNewswire/ -- Ibere Pharmaceuticals (the "Company") today announced that it will redeem all of its outstanding ordinary shares that were included in the โ€ฆSee details»

Ibere Pharmaceuticals Announces Closing of $138,000,000 Initial โ€ฆ

PHILADELPHIA, March 2, 2021 /PRNewswire/ -- Ibere Pharmaceuticals (the "Company") announced today that it closed its initial public offering of 13,800,000 units at $10.00 per unit, โ€ฆSee details»

Ibere Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks

Organization. Ibere Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. ... This โ€ฆSee details»

About Ibere Pharmaceuticals (IBER) - Investing.com

Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other โ€ฆSee details»

IBERE PHARMACEUTICALS (IBERU) Stock Price, Quote, News

IBERE PHARMACEUTICALS (IBERU) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.See details»

Ibere Pharmaceuticals Registered Stock Price - Markets Insider

Ibere Pharmaceuticals Registered -stock Ibere Pharmaceuticals Registered Shs -A- Called For Red 02.03.2023 At USD 10.17 A Sh Stock , IBER 0.00 0.00 0.00%See details»

Ibere Pharmaceuticals Announces Pricing of Upsized $120,000,000 โ€ฆ

PHILADELPHIA, Feb. 26, 2021 /PRNewswire/ -- Ibere Pharmaceuticals (the "Company") announced today that it priced its upsized initial public offering of 12,000,000 units at $10.00 โ€ฆSee details»

Ibere Pharmaceuticals Stock Price Today - Investing.com

View today's Ibere Pharmaceuticals stock price and latest IBER news and analysis. Create real-time notifications to follow any changes in the live stock price.See details»